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Abbreviation list 
BW body weight 
EAA  essential amino acids  
FFM  fat-free mass 
FM  fat mass 
HGS  hand grip strength 
IU  international units 
LBM  lean body mass  
LM lean mass 
SMD  standard mean difference 
TUG  timed up and go 
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Abstract 1 
The purpose of this systematic review and meta-analysis was to assess the effec-2 
tiveness of dairy components on nutritional status and physical fitness in older 3 
adults, as evidence for efficacy of the supplementation of these components is in-4 
conclusive. Scopus and MEDLINE were searched. Main inclusion criteria for articles 5 
were: double-blind, randomized placebo-controlled trials including participants aged 6 
≥55 years who received dairy components or a placebo. Outcome measures were 7 
nutrient status (body weight and BMI) and physical fitness (body composition, mus-8 
cle strength, and physical performance). Thirty-six trials with 4,947participants were 9 
included. Most trials investigated protein and vitamin D supplementation and showed 10 
no effect on the outcomes. Meta-analysis on the effect of protein on body weight 11 
showed a significant increase in mean difference (MD) of 1.13 kg (95% CI: 0.59 to 12 
1.67). This effect increased by selecting trials with study a duration of six months in 13 
which less nourished and physically fit participants were included. Trials where the 14 
participants were (pre-) frail, inactive older adults or when supplementing ≥20 grams 15 
of protein/day, tended to increase Lean Body Mass (LBM). Only small significant ef-16 
fects of vitamin D supplementation on Timed Up and GO (TUG) (MD -0.75 seconds; 17 
95% CI: –1.44 to -0.07) were determined. This effect increased when vitamin D dos-18 
es ranged between 400-1000 IU.  Additional large RCT trials of ≥six months are 19 
needed regarding the effect of dairy components containing an adequate amount of 20 
vitamin D (400-1000 IU) and/or protein (≥20 grams) on nutritional status and physical 21 
fitness in malnourished or frail older adults. 22 
  23 
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1. Introduction 26 
Malnutrition in older adults is considered to be a serious complication of illness and 27 
is associated with increased risks of mortality, longer hospital stays, frequent read-28 
missions [1], and a lower quality of life [2]. Malnutrition can result from starvation, 29 
disease, or advanced ageing (e.g. >80 years) and can be experienced alone or in a 30 
combination [3]. Moreover, malnutrition can influence the physical fitness, that exists 31 
out of body composition, muscle function, and physical function [4]. A decrease in 32 
muscle and physical function can pose difficulties in daily activities such as eating 33 
[5]. The comprehensive healthcare costs for malnourished institutionalized and 34 
community-dwelling older adults in Europe are considerably higher than for well-35 
nourished older adults [6]. Therefore, prevention of malnutrition in the elderly popula-36 
tion is an important strategy for maintaining their quality of life and saving on these 37 
costs. 38 
Older adults are among the high risk groups for malnutrition [7] for at least two 39 
reasons. First, they may have decreased food intake due to “anorexia of ageing”, 40 
i.e., a physiologic loss of appetite [8,9] or nutrition impact symptoms caused by ill-41 
ness or medical treatment. For example, difficulties with chewing and swallowing, 42 
pain, alterations in taste [10], medication that decreases appetite or increases nutri-43 
ent losses, polypharmacy, dependency on help for consuming meals, and decreased 44 
thirst response [11,12] are frequently reported. Second, older adults are more prone 45 
to the onset of chronic disease which can activate chronic inflammation [13,14] and 46 
consequently result in loss of muscle mass.  47 
  For older adults, protein requirements can be increased in various situations. 48 
For example, when a loss of muscle mass occurs, a high intake of protein is neces-49 
sary to stimulate muscle synthesis [15–17]. In addition to increased protein require-50 
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ments, energy requirements may be decreased in older adults mainly due to dimin-51 
ished physical activity and decreased basal metabolic rate during ageing. Nutrient 52 
requirements may also possibly increase for older adults [18] such as, discussed for 53 
vitamin D [19]. Therefore, this population experiencing unintended weight or appetite 54 
loss have an increased risk for nutrient deficiencies.  55 
 Dairy products can contribute to satisfying the macronutrient and micronutri-56 
ent insufficiencies in the diets of older adults. Various dairy components have been 57 
shown to enhance maintenance of bone mass and muscle mass [20–22]. Studies 58 
supporting the beneficial effects of milk or dairy products on bone health indicate a 59 
significant inverse association between dairy food intake and bone turnover markers 60 
and a positive association with bone mineral content [23]. Qualitative evidence is 61 
also available for the role of vitamin D and dairy consumption in promoting maximal 62 
bone health from childhood through young to late adolescence [24]. In addition to 63 
appropriate dietary calcium intake, sufficient serum vitamin D levels are important for 64 
skeletal health [25,26]. Vitamin D also stimulates gene expression by involvement in 65 
cell development, differentiation, and growth as well as stimulating muscle protein 66 
synthesis, and improving strength and balance [27,28].  67 
Milk protein consists of whey with a high amount of leucine which has been suggest-68 
ed as being responsible for the enhancing ability to stimulate muscle protein anabo-69 
lism [20,21], which is confirmed by a meta-analysis when combined with physical 70 
activity [22]. According to the digestible indispensable amino acid score (DIAAS) of 71 
the Food and Agricultural Organization [29], dairy proteins score among the highest 72 
in quality even though the presence of leucine was not yet taken into account in this 73 
scoring [28]. In a statement from the European Society for Clinical and Economic 74 
Aspects of Osteoporosis and Osteoarthritis (ESCEO), the pathways through which 75 
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dietary protein influences muscle synthesis are either via the activation of mTOR and 76 
aromatic amino acids, or via an increase in serum IGF-I. IGF-I can directly affect 77 
both muscle synthesis, but also indirectly via vitamin D, as increases in serum IGF-I 78 
also stimulates the renal production of 1,25(OH)D3 (Fig. 1) [30–33]. Via the vitamin 79 
D receptors in muscle tissue, 1,25(OH)D3 contributes to improved balance and 80 
physical function. Supplementation has a greater effect on fall risk than on muscle 81 
strength [34]. In addition to containing protein, vitamin D, and calcium, (fortified) dairy 82 
products are rich in nutrients that are essential for good bone health including zinc, 83 
vitamin B12, potassium, and phosphorus [35]. 84 
Although some evidence for the role of dairy components in physical perfor-85 
mance and bone health seems apparent, there is insufficient knowledge about the 86 
effect of dairy components on body composition and muscle strength in older adults. 87 
One review states that dairy component protein has a positive effect on muscle mass 88 
and strength and that low levels of 25(OH)D are associated with low muscle perfor-89 
mance and postural instability. Additionally, it is stated that the supply of both vitamin 90 
D and dietary protein could have a beneficial effect on muscle mass and strength, 91 
but mechanisms of interaction remain unclear [30]. Another systematic review of two 92 
Randomized Controlled Trials (RCTs) about sarcopenic obese older adults found no 93 
effect from 15 gram of protein (through cheese consumption) and no effect from  a 94 
high-speed circuit resistance training intervention [36]. To the best of our knowledge, 95 
there has been no systematic review and meta-analysis that investigated the effec-96 
tiveness of dairy components on nutritional status and physical fitness in healthy 97 
older adults, much less in frail or malnourished older adults. Moreover, the quality of 98 
most studies is disputable due to the lack of comparison with a placebo and poor 99 
randomization, concealment of allocation, and blinding. Therefore, the purpose of 100 
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this systematic review and meta-analysis was: 1) to review medium-to-high quality 101 
trials in order to assess the effectiveness of dairy or dairy components on the nutri-102 
tional status and physical fitness in older adults aged 55 years or older and 2) to 103 
identify the most effective treatment based on target groups, intervention duration, 104 
and doses, as a basis for future practical recommendations. Our hypothesis is that 105 
dairy or dairy components have a beneficial effect on nutritional status and physical 106 
fitness in older adults.  107 
 108 
2. Approach 109 
This systematic review and meta-analyses were performed in accordance to the Pre-110 
ferred Reporting Items for Systematic Reviews and Meta-analyses(PRISMA) guide-111 
lines [37]. 112 
 113 
 114 
2.1. Search strategy 115 
Relevant studies were searched in the electronic databases of Scopus and PubMed 116 
until March 2, 2016. No limits were established for the date of publication and for 117 
PubMed, however, the filter humans was activated. A combination of Medical Sub-118 
ject Headings (MeSH) and Boolean operators were used. The most significant key 119 
terms that were employed included: aged AND Malnutrition AND “Dairy product*” OR 120 
Vitamin D* AND “Body weight” OR “physical perform*” OR Muscles. 121 
 122 
 123 
2.2. Inclusion and exclusion criteria  124 
Double-blind, randomized placebo-controlled trials were included when using at least 125 
one of the following components present in dairy as an intervention agent: protein, 126 
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amino acids, calcium, zinc, selenium, iodine, potassium, phosphorus, magnesium, 127 
vitamin B2, vitamin B3, vitamin B12, vitamin K, or vitamin D as supplementation in 128 
addition to the habitual intake. Sources of the intervention components were not re-129 
strictively dairy-based, however, they should be present in dairy as a component. 130 
Studies with a nutritional intervention in addition to exercise were also included. 131 
Studies based upon only dietary advice were excluded. The control group was re-132 
quired to receive a placebo tablet or capsule or a ‘regular’ food product that was 133 
compared to the intervention substance. Studies that included ‘usual practice’ in-134 
stead of a placebo in the control group were excluded. Furthermore, studies of men 135 
and women aged 55 years and older who did not have having any type of kidney 136 
dysfunction requiring adherence to a protein restricted diet were included in this sys-137 
tematic review and meta-analysis. All inclusion and exclusion criteria are indicated in 138 
Table 1.  139 
 140 
 141 
2.3. Article eligibility 142 
The title and abstract of every record that was retrieved based on a selection of rele-143 
vant keywords were screened for relevance and eligibility by one reviewer. In addi-144 
tion, reference lists of review articles and articles that underwent full-text selection 145 
were screened for other relevant articles. Full-text articles were further assessed for 146 
eligibility based on the inclusion and exclusion criteria by two reviewers independent-147 
ly. In the event of uncertainty regarding eligibility of the article or unclear results due 148 
to incomplete information, the authors of the article were contacted for additional in-149 
formation. If no clarification was provided after the contact, the trial was excluded 150 
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from further review, however, when the author provided data, the meta-analysis was 151 
adjusted accordingly.  152 
 153 
 154 
2.4. Data extraction 155 
Two reviewers extracted the data of the eligible full text articles on the study charac-156 
teristics, i.e., mean age, location of study, the amount, type, and duration of interven-157 
tion, and outcome measurements. When the two reviewers did not agree on a deci-158 
sion, one of the co-authors was asked for an opinion. Final decisions were made by 159 
consensus based on the best argument. 160 
 161 
 162 
2.5. Quality assessment 163 
The quality of the methodology of the RCTs was also assessed by the two reviewers 164 
using the standardized assessment protocol from the Cochrane Collaboration with a 165 
score system [38]. A total of 11 criteria were assessed for each study in order to test 166 
the internal and external validity (Table 2). Per criteria, a maximum of three points 167 
and a minimum of one point could be scored where the maximum score indicated a 168 
low risk of bias. Trials that scored the highest points per criteria were selected for an 169 
additional meta-analysis that we refer to as a sensitivity analysis.   170 
 171 
 172 
2.6. Primary outcome measures 173 
The two main outcome measurements investigated in this systematic review were 174 
nutritional status including body weight and BMI and physical fitness, i.e., body com-175 
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position, muscle strength, and physical performance. Physical performance includes 176 
combinations of walking speed, chair stand, TUG, and balance time [39–43]. 177 
 178 
 179 
2.7. Meta-, subgroup-, sensitivity analysis and funnel plots 180 
Meta-, subgroup-, sensitivity analyses and funnel plots were performed when at least 181 
three studies per outcome measure were found. The data for meta-analyses were 182 
either directly extracted from the article as mean difference (MD) values with accom-183 
panied standard deviation for the intervention and control group or calculated sepa-184 
rately for both by subtracting the post-test mean from the baseline mean. Standard 185 
deviations of the mean differences not provided by a report were estimated with the 186 
use of a within-subject correlation coefficient of 0.5 [44]. Robustness of this assump-187 
tion was tested by applying sensitivity analyses on lower (0.3) and higher (0.8) corre-188 
lation coefficients as well. Meta-analyses were performed in Reman (version 5.3), 189 
and data are reported as estimated pooled mean differences with 95% CIs. A p-190 
value of 0.05 or smaller is considered significant for a treatment to be effective in 191 
changing the outcome. The sample size of participants was indicated by n while the 192 
number of included trials in the meta-analyses was defined as N. For the outcomes 193 
‘physical performance’, ‘walking capacity’, and ‘leg strength’, the standardized mean 194 
difference (SMD) was used as the summary statistic in the meta-analyses. SMD was 195 
utilized instead of MD when all of the trials assessed the same outcome but meas-196 
ured it by different methods [44]. The SMD expresses the size of the intervention 197 
effect per trial relative to the variability observed in that trial [44]. All other results 198 
were reported as mean ± SD unless stated otherwise.   199 
 We did not restrict the literature search for gender, but recorded this variable 200 
as a pre-specified factor for subgroup analyses when applicable. In addition, sub-201 
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group analyses were performed on study duration in months; composition of the in-202 
tervention component; intervention dose; several target populations; and exercise 203 
training. Sensitivity analyses were conducted based on the risk of bias assessment 204 
by only including trials in the analysis that scored the highest points for each risk of 205 
bias on each assessment question, which indicates a low risk of bias. 206 
 207 
 208 
3. Results  209 
From an initial number of 3,475 articles identified in the search, 36 were included in 210 
the systematic review and, of these, 19 were suitable for meta-analyses (Fig. 2). In 211 
total, the 36 trials comprised a total number of 4,947 randomized participants ranging 212 
from 18 to 1,471 per trial (Table 3). Included trials were carried out in Australia, Bra-213 
zil, Chili, Finland, Iceland, Ireland, Italy, Japan, the Netherlands, Spain, Sweden, 214 
Switzerland, and the USA. The trials were conducted in the following settings: vari-215 
ous types of senior citizen care facilities (N=8), hospitals (N=1), fall clinics (N=1), 216 
outpatient clinics (N=1), or in the community (N=25).   217 
A substantial variety of types of nutritional supplementation was employed in 218 
the trials selected for this systematic review. We did not locate any articles regarding 219 
the effect of cheese, ice cream, yoghurt, buttermilk, kefir, cultured milk products, se-220 
lenium, iodine, vitamin B2, vitamin B12, phosphorus, potassium, magnesium, vitamin 221 
K, Vitamin B3, or zinc. Eighteen trials provided vitamin D supplementation 222 
[39,42,43,45–59] of which one provided the intervention group with an extremely low 223 
amount of vitamin D of 0.5 µg/day [46]. For this reason, the trial was excluded from 224 
all analyses. Fifteen trials used protein as an intervention [40,41,60–72]. A complete 225 
overview of all of the included trials and their intervention components is shown in 226 
Table 3.  227 
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Six trials used a factorial design, comparing a nutrition intervention with an 228 
exercise-type intervention, using a control activity for exercise (such as watching 229 
films, reading, singing and conversation [61,73], visits or phone calls [42], or a social 230 
program). In five other trials, participants received a resistance-type exercise training 231 
in addition to protein supplementation or a placebo [40,62–64,67]. 232 
 233 
 234 
3.1. Risk of Bias 235 
Only eight of the 36 trials confirmed proper concealment of allocation, i.e., using 236 
sealed envelopes or computer allocation [40–42,50,51,54,62,73]. The quality of the 237 
trials was lowest for the criteria blinding of outcome assessors and treatment provid-238 
ers. Details on quality assessment per study are shown in Table 4. 239 
 240 
 241 
3.2. Compliance 242 
In 18 trials, compliance was reported to be good (≥80%), and the other 18 trials did 243 
not report on compliance rate.   244 
 245 
 246 
3.3. Nutritional status 247 
One trial investigated the effect of whey protein drinks [60] on nutritional status as 248 
assessed by the Mini Nutritional Assessment (MNA) but did not show a significant 249 
improvement in MNA score.  250 
Fourteen trials investigated the effect of dairy components on body weight;  251 
two trials did not publish the summarized data for body weight [42,69], therefore, 252 
 
 
  
15 
 
could not be included in the meta-analysis. Three out of 14 trials ascertained a signif-253 
icant increase in body weight [40,60,69]. An overview of trials included in the sys-254 
tematic review and meta-analysis is depicted in Table 3.  255 
Eight trials with either protein or amino acid intervention were included in the 256 
meta-analysis on body weight [40,41,60,63–65,67,72]. A significant pooled MD in 257 
body weight was found between the protein and placebo group (n=418; MD 1.13 kg; 258 
95% CI: 0.59 to 1.67; I2=0%; p<0.0001) (Fig.3). 259 
 Restricting the meta-analyses to trials wherin a mixture of amino acids as 260 
supplementation was provided or excluding trials in which one specific amino acid 261 
was given also resulted in a significant body weight increase (n= 330; MD 2.16 kg; 262 
95% CI: 0.93 to 3.38; I2=0%; p=0.0006) [40,41,60,63,64]. This was also found when 263 
restricting to trials with a duration of at least six months (n=264; MD 2.09 kg; 95% CI: 264 
0.88 to 3.29; I2=0%; p=0.0007) [40,41,60,63,65]. Subgroup analyses on four trials 265 
that included participants who were at risk of malnutrition, malnourisment [60], or 266 
(pre-)frailty [40,41], and those who were bed rest patients and those older than 70, 267 
resulted in a substantial increase in body weight with a MD of 1.16 kg; 95% CI: 0.62 268 
to 1.71; I2=9%; p=0.0001. Restricting to the five trials in which ≥20 grams of protein 269 
per day was supplemented also resulted in a significant increase of body weight (MD 270 
1.55 kg; 95%: 0.75 to 2.35; I2=0%; p=0.0001).  271 
Finally, restricting to trials that included an exercise training component to 272 
both the intervention and control groups or when restricting to trials with sufficient 273 
blinding according to the risk of bias assessment resulted in a significant increase of 274 
body weight (n=179; MD: 0.78 kg; 95% CI: 0.06 to 1.51; I2=0%; p=0.03, n=235; and 275 
MD: 1.18; 95% CI: 0.55 to 1.82; I2=31%; p=0.0003, respectively). The funnel plot, 276 
subgroup and sensitivity analyses are shown in Supplemental Figure S1. As indicat-277 
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ed in Table 3, nine trials investigated the effect of dairy components on BMI. One out 278 
of nine trials reported a significant increase in BMI [69]. In this trial, an amino acid 279 
mixture [69] was provided as an intervention. 280 
 281 
 282 
3.4 Physical fitness 283 
Only one out of 14 trials determined a significant increase in LBM (Table 3). In that 284 
study, protein drinks in combination with resistance-type exercise training were com-285 
pared to a placebo drink combined with exercise training in frail older adults [40]. 286 
Compared to the other 14 trials, this trial did not specifically differ in intervention du-287 
ration or dose of the supplementation except that they included (pre)frail older adults 288 
in their trial while the other studies included well-nourished older adults. 289 
 A meta-analysis was performed on eight trials (n=474) that investigated pro-290 
tein supplementation [40,62–66,72,74] but did not show an effect in LBM (MD 0.03 291 
kg; 95% CI: -0.33 to 0.39; I2=0%; p=0.87) (Fig.4). Restriction to an intervention dura-292 
tion of at least six months resulted in the inclusion of four trials [40,41,63,65] but did 293 
not show a significant increase in LBM (n=258; MD 0.40 kg; 95% CI: -1.59 to 2.40; 294 
I2=0%; p=0.69). Restriction to trials in which ≥20 grams of protein supplementation 295 
was given per day, did not result in a significant increase in LBM (n= 221; MD of 0.60 296 
kg; 95% CI: -0.09 to 1.29; I2=0%; p=0.09) [40,41,63,72]. When including trials with 297 
(pre-) frail older adults [40,41] and compulsorily inactive older adults [72], the in-298 
crease of LBM was inconsequential (n=141; MD: 0.61 kg; 95% CI: -0.09 to 1.31; 299 
I2=0%; p=0.09). Finally, subgroup analyses including trials that intervened with pro-300 
tein supplementation as well as exercise showed no beneficial effect (n=303; MD -301 
0.18 kg; 95% CI: -0.61 to 0.26; I2=0%; p=0.42) [40,62–64]. 302 
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 None of the four trials investigating the effect of protein on regional leg LBM 303 
showed a significant difference between the intervention and placebo group. One  304 
trial investigated the effect of ß-Hydroxy-Methyl butyrate (HMB), arginine, and lysine 305 
supplementation [70] on FFM but failed to find a significant effect. One trial investi-306 
gated the effect of vitamin D on regional FFM, but the summarized data and result 307 
were not published [45]. Another study investigated the effect of six months of sup-308 
plementation with a protein drink on skeletal muscle index but did not show a con-309 
siderable difference between the intervention and placebo group [60].  310 
Thirteen trials investigated the effect of dairy components or vitamin D on total 311 
or regional fat mass. One out of the eight studies showed a significant increase in 312 
favor of protein supplementation on fat mass and found a substantial increase in fa-313 
vor of protein [40]. One trial providing calcium supplementation reported a significant 314 
decrease in fat mass in the active absorbable algal calcium (AAACa) group (but not 315 
in the calcium carbonate group) compared to the placebo group [75]. Trials investi-316 
gating the effect of leucine supplementation on leg fat mass [65,66] did not show a 317 
meaningful difference between the intervention and placebo groups over time. The 318 
one trial investigating the effect of vitamin D on regional fat mass did not publish the 319 
summarized data on regional fat mass but reported that the change in fat mass was 320 
not significant [45].  321 
One out of the three trials investigated the effect of dairy components on fat 322 
mass on calf, arm, waist, hip, trunk, and limb circumference or waist-to-hip ratio 323 
[42,67,70] and revealed a significant effect of HMB, arginine, and lysine on calf, trunk 324 
and limb circumference [70]. 325 
Five trials investigated the effect of protein supplementation and vitamin D on 326 
the fiber cross-sectional area (Table 3). A significant increase in total (combined type 327 
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I and type II) fiber cross-sectional area (FCSA) was found in only one trial in which 328 
vitamin D3 was supplemented [39]. Another trial confirmed the effect of vitamin D2 329 
on type II fiber diameter (mean percentage change of 96.5%±26.7%; -22.5%±6.7%, 330 
p<0.0001, respectively). The other three trials investigated the effect of protein sup-331 
plementation but did not show a significant effect [41,65,66].  332 
Table 3 indicates that 20 trials investigated the effect of dairy components and 333 
vitamin D on leg strength. Two of the 20 trials reported a significant increase in (left) 334 
leg strength in participants receiving vitamin D3 supplementation. These trials were 335 
different from the other studies as they included long-stay geriatric care residents 336 
who were given 800 IU per day [51] instead of 400 IU or high doses of vitamin D3 on 337 
monthly basis (150,000 IU once a month during the first two months followed by 338 
90,000 IU once a month for the last four months) [50]; a greater number of partici-339 
pants (n=242) [52] and a longer study duration of 12 months [52]. 340 
 Six trials that investigated vitamin D supplementation were included in the 341 
meta-analyses [42,48,49,52,57] which showed no significant effect of vitamin D on 342 
leg strength (n= 735; SMD 0.09; 95% CI: -0.05 to 0.24; I2=0%; p=0.22, Fig. 343 
5).Selecting trials with vitamin D doses between 1000 to 4000 IU did not result in an 344 
indication of a significant increase of leg strength (n=345; SMD 0.04; 95% CI -0.17 to 345 
0.26; I2=1%; p=0.69). When restricting to trials with a study duration of at least six 346 
months, no significant increase of leg strength was found (n=711; SMD 0.08; 95% CI 347 
-0.07 to 0.22; I2=0%; p= 0.31). When excluding studies with high loss to follow up, a 348 
significant increase in leg strength did not occur with a vitamin D supplementation 349 
(n=380; SMD 0.08; 95% CI: -0.07 to 0.22; I2=0%; p=0.31) [42,49,52]. With a re-350 
striction to trials with comparable baseline characteristics in the intervention and con-351 
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trol groups, an increase in leg strength also did not occur with a vitamin D supple-352 
mentation (n=581; SMD 0.13; 95% CI: -0.07 to 0.33; I2=0%; p=0.19) [42,48,52,57]. 353 
For the meta-analysis on six trials in which protein supplementation took place 354 
[40,41,62–65], there was no significant effect on leg strength (n=417; SMD 0.05; 355 
95% CI: -0.14 to 0.24; I2=0%; p=0.60, Fig. 6). Furthermore, no significant effect on 356 
leg strength was found after limiting to four trials that used six months of protein sup-357 
plementation (n= 193; SMD 0.05; 95% CI: -0.20 to 0.30; I2=0%; p=0.68) 358 
[40,41,63,65] nor when restricting to trials with protein supplementation of at least 20 359 
gram per day (n=193; SMD 0.05; 95% CI -0.23 to 0.34; I2=0%; p=0.71). 360 
 Two trials investigated the effect of vitamin D3 and calcium on ankle dorsiflex-361 
ion, hip abductor, hip extensor hip adductor [57], and hip flexor [50,57]. One trial did 362 
not publish the data or only reported the significance of the results [50]. One trial 363 
showed a significant increase in hip extensor (vitamin D group: 5.2±0.7 kg versus 364 
placebo group: 3.1±0.8 SE kg,) and hip adductor strength (vitamin D group: 3.4±0.5 365 
and placebo group: 2.1±0.6) when compared to the lowest tertile for hip extensor 366 
(≤11 kg) and for hip adductor (≤12 kg) [57]. 367 
 Eight trials studied the effect of dairy components and vitamin D on hand grip 368 
strength (Table 3). One trial did not publish the summarized data or significance for 369 
hand grip strength [71]. Four trials with vitamin D intervention were included in order 370 
to perform a meta-analysis with the outcome hand grip strength [42,48,49]. Two trials 371 
studied a daily dose of 400 IU vitamin D3 [42], and the other trial studied the effect of 372 
1000 IU vitamin D3 [49]. For one trial, we compared vitamin D and no training with a 373 
placebo and no training (Bunout 2006-A) but also vitamin D and training with a pla-374 
cebo and training (Bunout 2006-B) [42].  375 
 
 
  
20 
 
 Meta-analysis showed a non-significant MD of 0.40 kg; 95% CI: -1.11 to 1.92; 376 
I2=0%; p= 0.60 (Fig. 7) (n=222 participants). For the sensitivity analysis, a meta-377 
analysis was performed separately for trials with a low loss to follow-up, however, no 378 
significant increase of hand grip strength due to vitamin D supplementation was 379 
found (MD 0.52 kg; 95% CI: -12 to 2.15; I2=0%; p=0.54).  380 
Table 3 depicts that seven trials investigated the effect of dairy components 381 
and vitamin D on physical performance. Two of the seven trials studying the effect of 382 
protein drinks or vitamin D found a significant effect when compared to the placebo 383 
group [41,54]. These two trials differed with the other trials by including paticipants 384 
who were vitamin D deficient and attending a fall clinic or (pre-)frail older adults 385 
[40,54]. The other eight trials did not find significant improvement in physical 386 
performance. 387 
A total of four trials supplying vitamin D were included in the meta-analysis 388 
(Fig. 8). No effect from vitamin D supplementation on physical performance was 389 
found (SMD 0.12; 95% CI: -0.07 to 0.30; I2=57%; p=0.22). A subgroup analysis  was 390 
performed based on restricting to trials that gave vitamin D3 supplementation. How-391 
ever, no significant effect was determined (SMD 0.12; 95% CI: -0.07 to 0.31; I2=67%; 392 
p=0.21). The funnel plot on physical performance showed a small asymmetry, indi-393 
cating possible weak publication bias (Supplemental figure S8). 394 
 Ten trials investigated the effect of dairy components and vitamin D on walk-395 
ing capacity (Table 3). One study investigated with participants walking 50 feet but 396 
did not publish the summarized data or results [54]. Only one of the 15 remaining 397 
trials showed a significant increase in walking capacity as measured by the six 398 
minute walking test [71]. This study investigated the effect of a 12 gram amino acid 399 
mixture (L-leucine, L-lysine, L-isoleucine, L-valine, L-threonine, L-cysteine, L-400 
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histidine, L-phenylalanine, L-methionine, L-tyrosine, and L- tryptophan) per day 401 
compared to a placebo in a healthy elderly population for three months. Meta-402 
analysis was performed on three trials that investigated the effect of vitamin D 403 
supplementation on walking capacity (Fig.9). The SMD was 0.04; 95% CI: -0.17 to 404 
0.24; I2=0%; p=0.73. The funnel plot showed no signs of publiction bias.  405 
 Eight trials investigated the effect of dairy components or vitamin D on the 406 
timed chair stands (Table 3). Two trials did not report the effect size or the p-value of 407 
the duration of the chair stand [43,54]. Only one of the remaining seven trials 408 
showed a significant change in the duration of the timed chair stand using chairs that 409 
differed in height (36 cm, 47 cm and 53 cm). The test with the shortest chair showed 410 
a significantly higher score for the intervention group compared to the placebo group. 411 
This significant result was not found for the tallest chair [53]. The other trials did not 412 
report the height of the chair.  413 
Four trials investigated the effect of dairy components and vitamin D on bal-414 
ance (Table 3). Two trials did not report the summarized data or result [41,61]. The 415 
remaining trials did not show a substantial difference between the intervention and 416 
placebo group over time [49,73].  417 
 Table 3 shows that ten trials investigated the effect of dairy components or 418 
vitamin D on TUG. However, in one trial, no data or description of significance was 419 
provided (37). Only two of the remaining nine trials found a significant effect of vita-420 
min D or protein supplementation on TUG [57,70]. Six trials with vitamin D 421 
supplementation were included in a meta-analysis [42,48,49,52,56,57]. These six 422 
trials gave vitamin D3 [42,48,49,52] or vitamin D2 [56,57]. One trial used a 2x2 facto-423 
rial design with an exercise intervention and a control activity [42]. Meta-analysis 424 
showed a significantly decreased MD of -0.75 seconds; 95% CI: –1.44 to -0.07 425 
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seconds; I2=0%; p=0.03 (Fig. 10). 426 
 A significant effect on TUG was found after limiting to trials that used a daily 427 
vitamin D dose of 400-1000 IU (N=5; n=711; MD -0.81 seconds; 95% CI: -1.51 to -428 
0.11; I2=0%; p=0.02) [42,48,49,52,57] (Supplemental Figure S9). No significant ef-429 
fect was found after limiting the analysis to trials that included vitamin D3 as a sup-430 
plement: MD -0.70; 95% CI: -1.52 to 0.12; I2=0%; p=0.10 [42,48,49,52]. The sensitiv-431 
ity analysis was limited to trials with a low loss to follow-up [42,49,52,56]. It did not 432 
show a significant difference between intervention and placebo groups, MD -0.62; 433 
95% CI: -1.44 to 0.20; I2=0%; p=0.14.  434 
 435 
 436 
4. Discussion 437 
This systematic review and meta-analysis showed that the dairy components protein 438 
and vitamin D have beneficial effects for older adults. Protein supplementation 439 
increased body weight by 1.13 kg, and vitamin D supplementation increased 440 
physical fitness, measured as TUG improvement by 0.75 seconds. However, the 441 
majority of the trials found no effect on nutritional status or physical fitness from sup-442 
plementation with dairy components. No studies were determined to examine the 443 
effects of specific dairy products on any of the investigated outcomes. Leg strength 444 
was the most frequently studied outcome, i.e., in 20 studies, followed by body weight 445 
in 14 studies. The least studied outcome was hip muscle strength (two studies).  446 
The significant effect of protein supplementation on body weight found in this 447 
meta-analysis confirmed results from two earlier meta-analyses which showed an 448 
increase in body weight of 2.15 kg (95% CI: 1.80 to 2.49 [76] and 1.02 kg (95% CI: 449 
0.19 to 1.85) [77] due to protein-energy and leucine supplementation. The greater 450 
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increase in body weight found in one meta-analysis [76] can be explained by the 451 
amount of protein-energy supplementation in the included studies wiich ranged from 452 
175 to 1350 kcal/day compared to a maximal amount of 313 kcal/day provided in the 453 
trials included in our meta-analysis. This indicates that a larger amount of energy 454 
and protein is required in the event that more weight gain is warranted such as in the 455 
elderly that are more frail. When we restricted the current meta-analysis to studies 456 
that provided ≥20-grams protein per day, this resulted in an increased change in 457 
body weight (MD) from 1.13 kg to 1.55 kg. Substantial effects on body weight were 458 
also observed when restricting to studies of longer duration (MD 2.09 kg) or when a 459 
mixture of amino acids (MD 2.16 kg) was given. Similar results were found when re-460 
stricting to studies including older adults >70 years of age, those at risk for malnutri-461 
tion, or those who were already malnourished, (pre-) frail, or compulsory inactive 462 
(MD 1.16). When restricting to trials that combined protein supplementation and ex-463 
ercise training, a significant change in body weightwas found, although with a 464 
smaller effect size of 0.76 kg.  465 
In our systematic review, no effect from protein supplementation on physical 466 
fitness, measured by body composition components (e.g. LBM), muscle strength, or 467 
physical performance was ascertained. A potential explanation of the absence of 468 
significant results of protein on body composition measures by meta-analyses might 469 
be poor compliance. Although most trials did not report on the compliance rate, we 470 
found that protein intake in 50% of the individual trials of the current meta-analysis 471 
did not significantly differ from baseline in the protein group at follow-up. This indi-472 
cates that the compliance was low and that the effect of protein supplementation was 473 
not properly investigated. Moreover, in two trials, both the intervention and control 474 
groups had already complied with the daily protein intake guidelines [64,65] which 475 
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might not provide the opportunity to increase LBM by postprandial muscle protein 476 
synthesis. To achieve stimulation of muscle protein synthesis, an amount of 20-30 477 
grams of protein per meal has been suggested as being required for sufficient stimu-478 
lation of postprandial muscle synthesis [41,78]. This was partly confirmed in our sys-479 
tematic review; restriction to trials that supplemented ≥20 grams of protein per day or 480 
to trials which included (pre-) frail or compulsory inactive older adults resulted in a 481 
tendency towards an increase in LBM of 0.61 kg (p=0.09).  482 
We investigated the effect of the supplementation of dairy components on 483 
FFM; however, a meta-analysis was not possible due to a low number of trials. In 484 
contrast to other meta-analyses and systematic reviews [22,79], we found no signifi-485 
cant effect of protein supplementation on FFM. Cermak et al.[22] reported a pooled 486 
estimate of a 0.48 kg (95% CI: 0.10 to 0.85) increase in FFM due to protein supple-487 
mentation during prolonged resistance-type exercise training in healthy older adults. 488 
This finding is in accordance with a review that states that resistance training in 489 
combination with dietary protein or amino acids or protein supplementation has a 490 
positive effect on muscle strength, muscle mass, and also physical function in older 491 
adults [17]. Cermak et al.[22]included studies that did not apply to our two inclusion 492 
criteria regarding age which were being younger (aged 18 years and older) and the 493 
obligation of using a placebo as a control [80]. Our stricter inclusion criteria hindered 494 
us in including an adequate number of trials for a meta-analysis with FFM as out-495 
come and, therefore, sufficient power to detect any possible significant differences. 496 
The trial without a placebo [80] indicated a substantial increase in muscle mass and 497 
was also included in the other positive systematic review[79].  498 
 We found that the effect of vitamin D supplementation on TUG improved more 499 
profoundly when restricted to trials that provided a dose of 400-1000 IU (MD: -0.81 500 
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seconds; p=0.02). The actual proper dose of vitamin D supplementation is currently 501 
under discussion [81]. One trial found no effect of high monthly doses of 60.000 IU 502 
(2000 IU/d) vitamin D calcifediol on lower extremity function in older adults compared 503 
to a reference dose of 24.000 (800 IU/d) [81]. Their subgroup analysis even revealed 504 
that participants reaching elevated 25(OH)D levels between 111.8-247.3 nmol/L had 505 
the greatest chances of falling and had the most falls compared to participants with 506 
levels between 53.3-75.8 nmol/L [81]. Another systematic review states that a daily 507 
dose of at least 800 IU is required to improve muscle strength [82]. Unfortunately, 508 
there were too few trials to do a subgroup analysis on a specific daily dose such as 509 
800 IU or doses of vitamin D higher than 1000 IU per day. However, according to our 510 
meta-analysis, a regimen of dosing towards a daily dose of 400 to 1000 IU seems to 511 
be beneficial with a small reduction in TUG.  512 
Our systematic review and meta-analysis have several strengths and limita-513 
tions. A major strength is the strict selection criteria for the trials which only allowed 514 
randomized controlled trials that used a placebo and that had applied double blinding 515 
to ensure a high level of evidence due to a lower risk of bias. A second strength is 516 
the small degree of heterogeneity, indicated by I2, in the meta-analysis which makes 517 
comparison between trials reliable. Third, although the abstract and title selection 518 
were decided by one reviewer, the full text selection of articles was done carefully by 519 
two independent reviewers. Fourth, we performed funnel plots to assess possible 520 
publication bias and most of these showed no concern for it. The funnel plot on phys-521 
ical performance showed a small asymmetry, indicating possible weak publication 522 
bias. In addition to publication bias, we assessed the risk of bias per trial. Although 523 
the quality of studies could have been improved by more effective blinding of out-524 
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come assessors and treatment providers, the quality of included trials scored rather 525 
well since the inclusion criteria were strict.  526 
The first limitation of our systematic review and meta-analysis is that we could 527 
not draw a conclusion about the effect of specific dairy products on the outcomes of 528 
nutrient status or physical fitness, because studies where the intervention existed out 529 
of dairy products instead of only dairy components were not available. Second, the 530 
majority of the trials did not publish the mean change with its accompanying stand-531 
ard deviation nor the correlation coefficient which describes the association between 532 
baseline and final measurements across participants [44]. Another meta-analysis 533 
estimated a correlation coefficient of 0.98 for FFM, and 0.70 (protein) and 0.80 (pla-534 
cebo) for one repetition maximum (1-RM) strength based on trials in healthy younger 535 
(<50 yrs. old) and older participants (>50 yrs. old) [22]. We estimated the standard 536 
deviation change, by using a conservative correlation coefficient of 0.5 [83]. Howev-537 
er, a sensitivity analysis of different correlation coefficients showed that using a cor-538 
relation coefficient of 0.8 resulted in a significantly increased LBM due to protein. 539 
Similarly, a significant effect was found of vitamin D3 (excluding trials that supple-540 
mented vitamin D2) on TUG as well as when selecting trials that had a low loss of 541 
follow-up when applying a correlation coefficient of 0.8. Therefore, we may have un-542 
derestimated these effects. It would be beneficial if future scientific papers present 543 
the actual mean change with its accompanying standard deviations to enable more 544 
meta-analyses that are accurate and allow for higher levels of scientific evidence. A 545 
third limitation is that we included trials in which resistance-type exercise training 546 
was given to both the nutritional intervention and the control groups in order to in-547 
crease the number of included trials and, therefore, statistical power. However, we 548 
do not have information on the interaction of the nutritional intervention and the exer-549 
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cise training. Therefore it is not possible to differentiate the effect between the nutri-550 
tional intervention and interaction with the exercise component. However, a meta-551 
analysis did not show an increase in heterogeneity with the trials that included an 552 
exercise component. A fourth limitation is the rather low number of studies included, 553 
especially for the meta-,subgroup, and sensitivity analysis. This hampered a robust 554 
effect estimate for older adults who were more vulnerable and gender specific con-555 
clusions whereas others stated that protein and vitamin D supplementation have a 556 
beneficial effect on target groups who were malnourished, vitamin D deficient, or frail 557 
[41,81,84]. The next limitation was the extensive number of outcome measurements 558 
used in included studies to examine body composition and physical fitness. Uniformi-559 
ty in outcome measurements is important for delivering high quality evidence based 560 
on meta-analyses, and it brings more focus to practical advice for the health care 561 
setting. Finally, we had a low response rate on our attempts to contact authors to 562 
request missing or additional details on their published data.  563 
 564 
 565 
5. Conclusion 566 
Most of the trials included in this systematic review showed no effect of dairy com-567 
ponents that were provided in addition to the habitual intake on nutritional status and 568 
physical fitness. However, based on the current meta-analysis, we conclude that 569 
protein supplementation increases body weight. This effect was greater after select-570 
ing trials with a study duration of six months and when participants were at risk for 571 
malnutrition, malnourished, or (pre-)frailty, were bed rest patients, or were older than 572 
70 years. The increase in body weight tended to be explained by differences in LBM 573 
but only when supplementing doses of protein higher than 20 g/d or when giving pro-574 
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tein supplementation to (pre-) frail or compulsorily inactive older adults. In addition, 575 
the meta-analysis showed that vitamin D can improve physical performance as 576 
assessed by TUG in older adults. No other beneficial effect of dairy components on 577 
muscle strength, hand grip strength, overall physical performance, walking capacity, 578 
or balance could be substantiated in this systematic review and meta-analysis. 579 
Publication bias was nearly nonexistent, and heterogenity between trials was 580 
minimal.  581 
 582 
 583 
6. Recommendations for future research 584 
More double-blind, randomized placebo-controlled trials should be undertaken in frail 585 
or malnourished older adults instead of healthy community-dwelling older adults. The 586 
effect of additional dairy components seems to be of little clinical relevance in 587 
healthy older adults but appears to be higher older adults that are more vulnerable. 588 
Additionally, doses of 400-1000 IU of vitamin D supplementation seem beneficial for 589 
physical performance, but supplementation doses of 800 IU are hypothesized to be 590 
more beneficial than 400 IU for muscle strength [77]. Therefore, future research 591 
should focus on doses of approximately 800 IU in order to test this hypothesis. Final-592 
ly, the combination of dairy components in one intervention should be studied to see 593 
if the combination of adequate vitamin D and protein is more effective than either of 594 
them alone. 595 
 596 
 597 
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Fig. 1 Dietary protein increases serum levels of amino acids and IGF-I. Amino acids 
are the most potent activators of mTOR, that stimulate muscle protein synthesis and 
hence hypertrophy, and consequently muscle strength. Increases in serum IGF-I also 
stimulates the renal production of 1,25(OH)D3. IGF-I insulin-like growth factor-I; 
mTOR, mammalian target of rapamycin; 1,25(OH)D2D3, 1,25-dihydroxyvitamin-D3. 
Adopted from Bonjour et al. 2007 and Rizzoli et al. 2014 [30,31] 
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Table 1. Inclusion and exclusion criteria for including studies in the systematic review 
  Inclusion Exclusion 
POPULATION • Adults aged 55 years or older 
 
• Animal studies 
• Children 
• Pregnancy or lactat-
ing 
• Athletes / body build-
ers 
• Renal dysfunction 
INTERVENTION • Randomized double-blind, place-
bo-controlled trials  
• Dairy, or dairy specific components 
(not mandatory to be dairy-based) 
• Vitamin D   
• Dietary counseling 
only  
• Nutritional supple-
mentation products 
that also give other 
micronutrients that 
are not present in 
dairy 
• Regular or usual care 
as reference in case 
intervention consisted 
of supplement 
• Small amounts of in-
tervention component 
where there could not 
be an expected effect 
based on outcomes 
relevant for this re-
view and meta-
analysis 
OTHER • Articles written in English 
• Full text articles only 
 
• Reviews  
• Conference articles 
• Letters 
• Notes 
• Short surveys  
• Editorials  
• Book chapter 
• Duplicate publications 
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Table 2. Quality assessment criteria and scored risk of bias table.  
A: Was the assigned treatment adequately concealed prior to alloca-
tion?  
3= Method did not allow disclosure of assignment 
2= Small but possible chance of disclosure of assignment 
1= States random, but no description or quasi-randomized 
B1: Were all randomized participants accounted for? 
3 = Yes 
2 = Partial description; some uncertainty 
1 = Inadequate detail 
B2: How many participants were lost to follow-up or otherwise ex-
cluded from the analysis? 
3= 0-10% 
2=>10-20% 
1= >20% 
C: Were the outcome assessors blinded to treatment status? 
3= Effective action taken to blind assessors 
2= Small or moderate chance of unblinding of assessors 
1= Not mentioned or not possible 
D: Were the treatment and control group comparable at entry?  
3= Good comparability of groups, or confounding adjusted for in analysis 
2= Confounding small; mentioned but not adjusted for 
1= Large potential for confounding, or not discussed 
E: Were the subjects blind to assignment status after allocation? 
3= Effective action taken to blind subjects 
2= Small or moderate chance of unblinding of subjects 
1= Not possible, or not mentioned (unless double-blind), or possible, but 
not done 
F: Were the treatment providers blind to assignment status?  
3= Effective action taken to blind treatment providers 
2= Small or moderate chance of unblinding of treatment providers 
1= Not possible, or not mentioned, or possible, but not done 
G: Were the inclusion and exclusion criteria clearly defined? 
3= Clearly defined 
2= Poorly defined 
1= Not defined 
H: Were the outcome measures used clearly defined? 
3= Clearly defined 
2= Poorly defined 
1= Not defined 
J: Was ascertainment of the outcomes reliable? 
3= “Golden standard” was used to measure outcome 
2= Validated method, but not the “golden standard” 
1= Not possible, or not mentioned, or possible, but not done 
K: Was the duration of surveillance clinically appropriate? 
3= 6 months or more  
2= 3 months to less than 6 months  
1= Less than 3 months or not defined 
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Fig. 2 Flow-chart of article selection for systematic reviewing and meta-analysis 
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Table 3: Overview of studies included in the systematic review and meta-analysis.  
Reference (pri-
mary author and 
year) 
Study  
population; age; 
mean (range); place 
of study 
Intervention Compliance Treat-
ment 
duration  
Outcome measure-
ments 
Effect on outcome 
Björkman 2012 
[60] 
 
 
103 men and women 
from a single center 
municipal nursing 
home; age: 83.5±8.2 
y; Helsinki, Finland. 
20 g protein in 4.5 dL of 
juice/day for test group. 
45 kcal of energy, 11 g 
carbohydrates, 1 g fiber, 
and 40 mg of vitamin C/ dl 
in test drink and placebo 
drink without protein.  
Intervention 
group: 
81.8±18.1%, Con-
trol: 73.9±24.8% 
(P = 0.263) 
 6 months HGS, Body Weight (BW), 
Fat-Free Mass (FFM), 
Mini Nutritional Assess-
ment (MNA) and Im-
proved MNA score. 
Weight showed a higher mean change over 6 
months-period compared to the control group. The 
mean change of FFM, and HGS between the two 
groups did not differ significantly.  
Reid 2005 [85] 1471 healthy women 
who are ≥5y post-
menopausal and 
≥55y; Intervention: 
74.2±4.2, placebo: 
74.3±4.3. 
1 g elemental calcium 
daily (in form of 2 tablets 
in morning and 3 tablets 
in the evening) as citrate 
or identical placebo. 
Intervention: 78%; 
Control: 80% (= 
0.26) 
30 
months 
BW, BMI, Fat Mass (FM), 
and Lean Body Mass 
(LBM) (DXA). 
Weight decreased in both groups, but the differ-
ence was not significant (P=-0.93). Fat and LBM 
did not show an effect of calcium. 
Bunout 2006 
[42] 
48 healthy older 
adults living in the 
community; 76 ± 4 y; 
Chili. 
 
 
 
Daily, vitamin D3 (vitamin 
D3)) 400 IU + 800 mg 
calcium or calcium alone 
as control. 
92±3% in both 
intervention and 
control group. 
9 months Body composition: Lean 
Mass (LM), FM, arm 
circumference, waist 
circumference, hip cir-
cumference, HGS, gen-
eral physical fitness 
(TUG) and physical per-
formance (Short Physical 
Battery=SPPB).  
Gait speed increased in supplementation group 
(whether trained or not) than in non-supplemented 
subjects (P = 0.02). No significant changes were 
found in weight, circumferences or body composi-
tion in any of the four groups. 
Carlson 2011 
[61] 
94 people; 65-99 y 
with severe physical 
or cognitive impair-
ments, and living in 
residential care facili-
ties; Umeå, Northern 
Sweden. 
2x2 factorial model exer-
cise intervention com-
pared with a control activi-
ty and an intake of a 
protein-enriched drink 
(200 ml) compared to a 
placebo. The intervention 
drink contained 7.4 g 
protein, 15.7 g carbohy-
drate, and 0.43 g fat; the 
placebo drink contained 
0.2 g protein and 10.8 g 
carbohydrate. Subjects 
got the drink 5 times per 
two weeks.  
Protein drink: 
84%; placebo: 79. 
The protein 
Drink package 
was completely 
taken in on 82% 
and the placebo 
drink on 80%. 
3 months Body composition (FFM, 
Intra Cellular Wa-
ter=ICW, BW), BMI and 
Berg Balance Scale. 
No significant differences in ICW, muscle mass, 
BW, Berg Balance scale in the protein group com-
pared to the placebo group after 3 months or 6 
months. The within group analyses in people with 
MNA ≤17 showed no significant changes in ICW 
and BW either in exercise group (0.9 l, p = 0.410 
vs -0.9 kg, p = 0.185) or in control group (0.3 l, p = 
0.673 vs -0.5 kg, p = 0.548). 
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Ceglia 2013 [39] 21 ambulatory, com-
munity-dwelling, 
postmenopausal 
women 78±5yrs. 
Daily oral vitamin D3 
capsule 
(4000 IU) or matching 
placebo. 
No information 4 months SPPB No changes in total SPPB score by group (P= 1.0).  
Corless 1985 
[53] 
65 patients in the 
geriatric wards of four 
hospitals; interven-
tion: 82.6 y (6.9) 
mean (SEM), place-
bo: 82.3 y (6.0); Eng-
land. 
9000 unit’s vitamin D2 or 
identical looking placebo.  
Intervention group 
showed no signifi-
cant increase in 
serum vitamin D 
at follow-up, sug-
gesting low com-
pliance.  
2 months Muscle function score. No significant differences were found for muscle 
function between the two groups before or at any 
time during the trial. 
Dawson-Hughes 
1991 [47] 
246 postmenopausal 
women; intervention: 
61.4±0.5 y, placebo: 
61.9±0.5 y; USA.  
400 IU vitamin D + 127 
mg calcium (calcium 
phosphate) or placebo 
with 127 mg calcium. 
Additionally, all subjects 
received 250 mg ele-
mental calcium (calcium 
citrate).  
Compliance was 
99%. 
12 
months 
Fat%, LBM, and muscle 
strength. 
There was no change or effect of vitamin D sup-
plementation on whole-body fat or lean-tissue 
mass during the study. Muscle strength did not 
differ between the groups during both periods.    
Dhesi 2004 [54] 
 
123 elderly men and 
women attending a 
falls clinic and with 
25OHD levels ≤12 
μg/l and normal bone 
biochemistry; inter-
vention group: 
77.0±6.3 y, placebo 
group: 76.6±6.1 y; 
London, UK.  
Single intramuscular 
injection of 600,000 IU 
vitamin D2. 
High compliance 
due to single 
injection of vitamin 
D2.   
6 months  Functional performance 
(Aggregate Functional 
Performance 
Time (AFPT)): 50 ft. 
walk, rising from a 42-cm 
high chair. 
The placebo group showed a 6.6 s deterioration in 
AFPT over the trial period; treatment group im-
proved by 2.0 s. This resulted in a significant dif-
ference in the change over 6 months between the 
two groups (P<0.01). Both groups showed a loss 
of strength over the trial period. 
Gallagher 2013 
[45] 
STOP IT: 488 elderly 
women; 71±4 y; USA. 
Twice daily, 0.25 mcg 
calcitriol, conjugated 
estrogens 0.625 mg daily, 
a combination of both or 
placebo. 
No information. 3 years Body composition: total 
and regional fat and LBM 
(DXA).  
No significant effect of calcitriol on total body fat 
(p=0.572) but a significant decrease in LBM at the 
end of the 3-year study (p<0.0001) in both groups 
(placebo and calcitriol) was found. In the placebo 
group, there was a significant decrease in LBM (p< 
0.0001) but not in total FM (p =0.628). There was 
no difference between the placebo and calcitriol 
groups in percent body FM (p = 0.410) or LBM (p 
= 0.921) at the end of the 3-year study.  
Janssen 2010 
[48] 
59 women with serum 
25OHD levels be-
tween 20-50 nmol/L, 
attending an outpa-
tient clinic of the De-
Daily 400 IU vitamin D 
(vitamin D3) +500 mg/day 
calcium, or identical pla-
cebo tablets + calcium 
500 mg/day. 
59-100% (average 
94.8%). 
6 months BW, HGS, Timed “Get 
Up and Go” test (TGUG) 
and habitual physical 
activity. 
No significant difference was found between the 
two groups at 6 months in HGS. In the analysis of 
variance, with handgrip strength as outcome, the 
intervention did not affect muscle strength com-
pared to placebo significantly.  
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partment of Geriatric 
Medicine; intervention 
group: 82.4±6.4 y, 
placebo group: 
79.2±6.7y; Utrecht.  
Kenny 2003 [49] 65 healthy, communi-
ty-dwelling men; 
76.7±4 y (65–87); 
Connecticut, USA.  
Daily vitamin D3 (1,000 
IU/d) + 500 mg calcium or 
a matching placebo pill 
with 500 mg calcium. 
No information. 6 months Handgrip strength, physi-
cal performance (ability 
to rise from a chair, static 
balance and the 8-foot 
walk, the timed ‘‘up and 
go’’ test, and the timed 
‘‘supine to stand’’ test). 
Time effects for handgrip strength and timed su-
pine to stand, were seen, but there was no time-
by-group effect for any of these measures. 
Leenders 2011 
[65] 
57 elderly males with 
type 2 diabetes; 71±1 
yr; Wageningen, The 
Netherlands. 
2.5 g L-leucine or placebo 
after each main meal. 
No information. 6 months Body composition (DXA): 
BW, LM, FM, regional leg 
mean mass, leg FM, fat 
percentage. 
Lean tissue mass did not change or differ between 
groups and any time point (0, 3 and 6 months). 
Also, no changes were found in body fat percent-
age. 
Lips 2010 [43] 213 men and women 
with insufficient vita-
min D serum values 
(≤50 but ≥15 nmol/L); 
placebo: 77.6±6.6 y, 
intervention: 78.5± 
6.2 y; North America 
and Europe. 
3 tablets once per week 
containing a placebo or 
2800 IU vitamin D3. Only 
for those with a daily 
dietary calcium intake 
<1000 mg, 500 mg ele-
mental calcium was pre-
scribed.  
No information. 4 months SPPB: balance tests, gait 
speed test (timed 4-m 
walk) and timed rising 
from a chair and sitting 
for 5 repetitions. 
After 16 weeks, SPPB did not differ significantly 
between treatment groups. 
Moreira-Pfrimer 
2009 [50] 
51 institutionalized 
living in two different 
long-stay geriatric 
care (LSGC) units; 
median age: 77.6, 
range 62–94 years; 
São Paulo, Brazil. 
Daily calcium plus month-
ly placebo 
(calcium/placebo group) 
or daily calcium plus oral 
vitamin D3 (150,000 IU 
once a month during the 
first 2 months, followed by 
90,000 IU once a month 
for the last 4 months 
(calcium/vitamin D group). 
High 6 months Maximum isometric 
strength of hip flexors 
(SHF) and knee exten-
sors (SKE).  
The placebo group showed no improvement in 
SHF and SKE at 6 months (p = 0.93 and p = 0.61, 
respectively), SHF and SKE was increased in the 
intervention group (p=0.0001 and p=0.0007).  
Fujita 2004 [75] 58 hospitalized elder-
ly women; group A: 
80±6 y, group B 83±6 
y and group C: 79±9 
y; Osaka, Japan. 
Group A got 900 mg/day 
Ca supplement as AAA 
Ca, group B got 900 
mg/day Ca supplement in 
de form CaCO3 and 
group C got the placebo. 
Participants were in-
structed to take two cap-
sules after each meal 
No information 2 years Whole body mass, fat 
content, lean content 
measured by DXA and 
BW.  
Whole body mass, lean content expressed as a 
percentage of whole body mass, remained the 
same in the three groups. However, increase of fat 
content was significantly decreased in group A 
compared to group C, but not in group B com-
pared to group C. 
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daily. 
Smedshaug 
2007 [59] 
60 nursing home 
residents; 
mean age of 85 y;  
Intervention group: 5 ml 
cod liver oil p/d containing 
10 mg vitamin D3; The 
control group received 5 
ml cod liver oil p/d without 
vitamin D. 
No information 1 year Grip strength Grip strength did not improve in the vitamin D 
group (0.4 kg increase) compared with the control 
group (1.6 kg increase) after 1 year vitamin D 
supplementation (p=0.22).  
Solerte 2008 
[69] 
41 consecutive elder-
ly outpatients with 
sarcopenia and re-
duced whole-body 
lean body mass; age 
range: 66–84 y; Italy.  
The oral AA mixture and 
an isocaloric placebo 
were ingested as snacks 
at 10:00 AM and 5:00 PM. 
The AA preparation (70.6 
kcal/day) contained 8 
g/day of AAs (L-leucine, 
2.5 g; L-lysine, 1.3 g; L-
isoleucine, 1.25 g; L-
valine, 1.25 g; L-
threonine, 0.7 g; L-
cysteine, 0.3 g; L-
histidine, 0.3 g; L-
phenylalanine, 0.2 g; L-
methionine, 0.1 g; L-
tyrosine, 0.06 g; and L-
tryptophan, 0.04 g). The 
trial had a cross-over 
design. 
No information 18 
months 
Mean whole-body mass, 
BMI, FM 
Mean values of BMI significantly increased in the 
AAs group (p=0.05) and in the placebo group 
(p=0.01); whereas the total body FM remained 
unchanged throughout the study. Whole-body 
LBM increased significantly after six months and 
more consistently after 18 months of oral nutrition-
al supplementation with AAs 
Rosendahl 2006 
[73] 
86 elderly dependent 
in activities of daily 
living; intervention 
group: 82.9±6.4 y, 
placebo group 
85.6±7.0 y; Umeå 
Sweden. 
 Milk-based nutrient drink 
(200 ml) that contained 
7.4 g protein, 15.7 g car-
bohydrate, and 408 kJ per 
100 g. The placebo drink 
(200 ml) contained 0.2 g 
protein, 10.8 g carbohy-
drate, and 191 kJ per 100 
g. This study had a 2x2 
factorial design with exer-
cise as an intervention 
and a control activity.  
The protein-
enriched energy 
supplement: 82%; 
placebo drink: 
78%. Package 
completely emp-
tied: 80%. 
6 months Berg Balance Scale, 2.4 
meters timed test, and 
modified chair-stand test. 
Berg Balance Scale, self-paced and maximum gait 
speed were followed-up at three and six months. 
No interaction effects were seen between the 
exercise and nutrition interventions. There was a 
significant difference in self-paced gait speed in 
favor of the placebo group at six months compared 
to the nutrition intervention group. For other out-
comes, there was no significant effect for both the 
intervention group and placebo group.  
Sato 2005 [55] 96 elderly women 
who were hospitalized 
stroke patients with 
hemiplegia; Placebo 
Daily dose of 1,000 IU 
vitamin D2 or 
placebo. 
No information. 2 years  Muscle strength and 
muscle biopsy. 
Increases in the relative number and size of type II 
muscle fibers and improved muscle strength was 
found in the vitamin D-treated group compared 
with the placebo group. Type I fibers was not dif-
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group: 74.2±4.1 y, 
Intervention group: 
74.1±3.9 y; Japan. 
ferent in the intervention group compared to the 
placebo group. 
Tieland, van de 
Rest 2012 [41] 
61 prefrail and frail 
elderly; placebo: 81± 
1 y, intervention: 78±1 
y; The Netherlands. 
Daily, either 2 times bev-
erages (250 mL) contain-
ing 15 g protein (milk 
protein concentrate, 7.1 g 
lactose, 0.5 g fat, and 0.4 
g calcium), or a matching 
placebo containing no 
protein, 7.1 g lactose, and 
0.4 g calcium. 
92% 6 months Skeletal muscle mass, 
FM, BW, HGS and phys-
ical performance (SPPB). 
Skeletal muscle mass did not change in the inter-
vention or placebo group during 6 months of inter-
vention. Physical performance improved signifi-
cantly in the intervention group and did not change 
in the placebo group. HGS did not significantly 
differ in the intervention group compared to the 
placebo group at the end of the intervention.  
Witham 2010 
[56] 
91 elderly patients 
with systolic heart 
failure and 25-
hydroxy vitamin D 
level of <50 nmol/L 
(20 ng/mL); placebo 
group: 80.6±5.7 y, 
intervention group: 
78.8±5.6 y; UK. 
Oral dose (100 000 IU 
vitamin D2 or placebo) 
was administered after 
baseline outcome 
measures and again after 
10 weeks. 
High 5 months 6-minute walk test, TUG-
test and daily physical 
activity Levels. 
The 6-minute walk test, TUG-test and daily activity 
did not significantly improve in the treatment group 
relative to placebo. 
Zhu 2010 [57] 261 community-
dwelling ambulant 
elderly women with 
serum 25-
hydroxyvitamin D 
concentrations <24 
ng/mL; placebo 
group: 77.0 ±4.8 y, 
intervention group: 
76.8±4.2 y; Perth, 
Australia. 
Vitamin D2 1,000 IU/d or 
identical 
placebo; calcium citrate (1 
g calcium/d) in both 
groups 
Vitamin D group: 
86.7%; placebo 
group: 86.8%. 
1 year  TUG-test. In the lowest tertile, vitamin D improved TUAG 
more than calcium alone (P=0.05).  
Bischoff 2003 
[51] 
62 elderly women in 
long-stay geriatric 
care; 85.3 y (63-99 y); 
Switzerland.  
Daily 2 tablets containing 
600 mg calcium car-
bonate and 400 IU vita-
min D3 per tablet or 2 
tablets containing 600 mg 
calcium carbonate.  
Out of 89 partici-
pants, ten had a 
decreasing com-
pliance.   
3 months TUG-test, and grip 
strength.  
Musculoskeletal function improved significantly in 
CAL+D-group compared to CAL-group (No P-
value for TUG was published). 
Del Favero 2012 
[68] 
18 healthy older 
adults; Intervention 
group: 65±4 y, place-
bo group: 64±7 y; Sao 
Paolo, Brazil.   
3.2 g beta-alanine (2 
tablets x 800 mg given 
twice per day after lunch 
and dinner) or an identical 
placebo 
100% (self-
reported) 
3 months Muscle function test 
(timed stands and TUG-
test) and physical func-
tioning.  
No significant changes between intervention and 
placebo group was observed for the timed stands 
and TUG-test after beta-alanine supplementation 
when compared to the placebo group.  
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Flakoll 2004 [70] 29 women recruited 
from senior citizen 
centers and adult 
assisted-living and 
care facilities; 
81.1±1.8 y. 
Orange drink, which con-
tained HMB (Calcium 
HMB, 2 g), arginine (5 g), 
LYS (lysine Hall, 1.5 g) 
and ascorbic acid (0.5 g) 
in 8 oz. of water 
(HMB/ARG/LYS. In S1, 
the placebo group con-
ceived: orange-flavored 
isocaloric drink of malto-
dextrin and ascorbic acid 
(0.5 g) in 8 oz. of water.  
100% 3 months Functionality (“get-up-
and-go” performance 
test, body composition 
(body fat% and FFM, 
trunk circumference 
(abdomen and hip), limb 
circumference (arm, 
forearm, and thigh) and 
trunk circumference 
(abdomen and hip).   
The HMB/ARG/LYS-supplemented subject’s sig-
nificantly improved get-up-and-go performance 
times compared to the placebo group. Although 
not statistically different, the HMB/ARG/LYS group 
had an increase in fat-free mass, whereas sub-
jects taking placebo showed a decrease in fat-free 
mass. FM and percentage of body fat were un-
changed in both groups.  
Pfeifer 2009 [52] 242 healthy ambula-
tory elderly women 
and men; Bad Pyr-
mont, Germany and 
Graz, Austria. 
Daily, one tablet contain-
ing 400 IU vitamin D3 and 
500 mg of elemental 
calcium (calcium car-
bonate) or one tablet with 
500 mg at breakfast and 
dinner together with the 
meals. 
No information. 12 
months 
TUG Significant improvements in timed-up-and-go test 
after 12 months in the calcium + vitamin D group. 
Scognamiglio 
2005 [71] 
95 healthy elderly 
subjects with reduced 
physical activity; AA-
group: 74±6 y, place-
bo group: 74± 5 y; 
Italy.    
12 g of AAs plus and 
12.21 g of glucose, or 
placebo containing 12.21 
g of glucose at 10.00 
a.m., 4.00 p.m. and 10.00 
p.m. The composition of 
the AA mixture (g/day): L-
leucine 3.8, L-lysine 2, L-
isoleucine 1.9, L-valine 
1.9, L-threonine 1.1, L-
cysteine 0.4, L-histidine 
0.4, L-phenylalanine 0.3, 
L-methionine 0.2, L-
tyrosine 0.1, and L-
tryptophan 0.1. 
Intervention: 86%; 
placebo: 87% 
3 months BMI, 6-min walk test. BMI did not change signiﬁcantly with intervention. 
The 6-min walk distance increased significantly in 
the AA-group, but not in the placebo group.  
 
Smidt  
1991 [86] 
80 healthy older 
adult’s women select-
ed from medical reg-
istration lists provided 
by the Southern 
Health Board of Ire-
land; Cork City, Re-
public of Ireland 
Thiamin-supplemented 
(10 mg daily) or placebo.  
95% 6 weeks  BW. BW did not differ between the two groups during 
baseline and treatment, and there were no differ-
ence in mean values when comparing baseline 
and treatment for the placebo group. In the thiamin 
supplemented group, mean BW increased signifi-
cantly during treatment compared to baseline 
values. Energy intake also increased significantly 
in the intervention group, but not in the placebo 
 
 
  
53 
 
group.  
Verhoeven 2009 
[66] 
29 healthy elderly 
men; 71±4 y; The 
Netherlands. 
2.5 g leucine or a placebo 
with each main meal 
(breakfast, lunch, and 
dinner). 
No information. 3 months  BW, whole-body and leg 
LBM, FM and leg fat. 
Whole-body, leg FM, fat-free mass (DXA), did not 
differ between groups before the intervention. No 
changes in body composition or muscle mass 
were observed over time, and no signiﬁcant differ-
ences were observed between groups. 
Verdijk 2009 [64] 26 healthy elderly 
men;72±2 in both 
groups; The Nether-
lands 
Resistance-type exercise 
training with protein sup-
plement (3 sessions/ 
week, 20 grams protein 
per session) or placebo.  
No information 3 months BMI, BW, leg mean 
mass, LM and FM. 
Leg muscle mass, BMI and BW did not significant-
ly differ from protein to placebo group.  
Tieland, Dirks, 
2012 [40] 
62 frail older adults 
78±1 y; The Nether-
lands.   
Resistance-type exercise 
training (2 sessions/week) 
with daily protein supple-
ment of 2 times 15 grams 
protein or placebo. 
No information. 6 months  
 
BW, LBM, FM, HGS, 
SPPB, gait speed, chair 
rise.  
LBM increased significantly in the protein group 
compared to placebo group. Physical performance 
increased in both groups, with no interaction effect 
of dietary intervention.  
Arnarson 2013 
[62] 
141 apparently 
healthy older adults; 
intervention group: 
73.3 ±6 y, placebo 
group: 74.6 ±5.8 y 
(range: 65-91); Capi-
tal area of Iceland. 
20 gram of whey protein 
or isocaloric placebo that 
was given 3 times per 
week during resistance 
exercise training.  
No information. 3 months LM, appendicular skeletal 
muscle mass, TUG, 6 
min walk for distance. 
No significant difference was found between the 
protein and placebo group after three months for 
LM, appendicular skeletal muscle mass, TUG, 6 
min walk for distance. 
Chalé 2013 [63] 75 mobility-limited 
older adults; age 
range 70-85 y; USA. 
Daily 40 gram of whey 
protein or an isocaloric 
placebo powder was 
given to subjects, both in 
combination with high-
intensity resistance train-
ing.  
No information. 6 months Body mass, LM, FM, 
chair-rise time, SPPB, 
and 400m walk. 
No outcomes scored significantly higher in the 
intervention group compared to the placebo group 
over time.  
Trabal 2015 [67] 30 older adults; Age: 
Leucine group: 85±8 
y, Control group: 4±4; 
Barcelona, Spain 
10 g/d of L-leucine or 
placebo (maltodextrin) 
and both groups had 
resistance training (3 
times/week)  
Intervention: 80%; 
placebo: 94%. 
3 months Physical Performance 
Battery (PPB): balance 
test, 4m walking speed 
test, 5 times chair rise 
test, and the TUG-test, 
MNA, BW, BMI, waist 
circumference, triceps 
skin fold, and calf circum-
ference.  
Mid-upper arm muscle area and TUG significantly 
improved in the intervention group compared to 
the placebo group. For the other outcomes, no 
significant between-group differences were found.    
Ferrando 2010 
[72] 
22 older adults; Age: 
control: 68±5 y, Inter-
vention: 71±6.72 y; 
3 times per day 15 g of 
EEA or placebo during 
constant bed rest (except 
No information. 10 days LM, leg LM, FM.   No significant effect of EAA on total or leg LM, FM, 
body mass. 
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USA.  when toileting). 
Schürch 1998 
[87] 
82 orthopedic ward 
patients; 80.7±7.4 y;  
550 mg/d calcium and 
one dose at baseline of 
vitamin D (200000 IU) for 
all patients and 20 g/d 
protein (90% milk pro-
teins) or placebo. Both 
powders contained: vita-
min A (1000 IU), vitamin 
K, (30 µg), vitamin C (20 
mg), calcium (550 mg), 
magnesium (91 mg), 
phosphorus (429 mg), 
and sodium (228 mg).  
No information.   6 months Muscle strength, BW, 
LM, FM and HGS. 
No significant between-group differences were 
found for biceps muscle strength, BW, LM, FM and 
hand grips strength.   
 
  
 
 
  
55 
 
Table 4. Risk of bias scores per trial.  
Reference A B1 B2 C D E F H J K L 
Bjorkman 2012 [55] 2 2 3 3 3 3 3 3 3 3 3 
Reid 2005 [80] 2 2 2 1 3 3 2 3 3 3 3 
Bunout 2006 [37] 3 3 3 2 3 3 2 3 3 2 3 
Carlsson 2011 [61] 2 3 2 1 3 2 1 3 3 2 2 
Ceglia 2013 [39] 1 3 2 2 3 2 2 3 3 3 2 
Dawson-Hughes 1991 [47] 2 2 2 2 3 3 2 2 3 2 3 
Dhesi 2004 [54] 3 3 2 2 3 3 3 3 2 2 3 
Gallagher 2013 [45] 2 3 3 2 3 3 3 3 3 1 3 
Janssen 2010 [48] 2 2 2 2 3 3 2 2 3 2 3 
Kenny 2003 [49] 2 3 3 2 2 3 2 2 2 2 3 
Leenders 2011 [65] 2 3 3 2 3 3 2 3 3 3 3 
Lips 2010 [43] 2 2 2 2 2 3 2 3 3 2 2 
Moreira-Pfrimer 2009 [50] 3 3 2 2 3 3 2 3 3 2 3 
Fujita 2004 [75] 2 1 1 2 3 3 2 2 2 3 3 
Smedshaug 2007 [59] 2 2 3 2 3 3 2 3 3 2 3 
Solerte 2008 [69] 2 1 1 1 1 2 1 1 2 3 3 
Rosendahl 2006 [73] 3 2 2 2 2 3 2 2 3 2 3 
Sato 2005 [55] 2 3 2 2 3 3 2 3 3 3 3 
Tieland 2012 [41] 3 3 3 3 3 3 3 3 3 2 3 
Witham 2010 [56] 2 3 3 3 3 3 3 3 2 2 2 
Zhu 2010 [57] 2 2 2 3 3 3 3 3 3 2 3 
Bischoff 2003 [51] 3 2 1 3 3 3 3 3 3 2 2 
Del Favero 2012 [68] 2 3 3 2 3 3 2 3 3 2 2 
Flakoll 2004 [70] 2 3 2 2 3 3 2 3 2 2 2 
Pfeifer 2009 [52] 2 3 3 2 3 3 2 3 3 2 3 
Scognamiglio 2005 [71] 2 2 3 2 3 3 2 3 3 2 2 
Smidt 1991 [86] 2 3 3 2 3 3 2 3 3 2 1 
Verhoeven 2009 [66] 2 3 3 2 3 3 2 2 2 2 2 
Verdijk 2009 [64] 2 3 3 2 3 2 2 2 3 2 1 
Tieland, Dirks 2012 [40] 3 3 2 3 3 3 3 3 3 2 3 
Arnarson 2013 [62] 3 2 3 3 3 3 3 2 3 2 2 
Chalé 2013 [63] 2 2 3 2 3 3 3 3 3 2 3 
Trabal (2015) [67] 2 2 1 3 3 3 3 2 3 2 2 
Ferrando (2010) [72] 2 2 2 1 3 3 1 3 3 2 1 
Schürch (1998) [87] 2 2 1 2 3 3 2 3 3 2 3 
Letters and scores are assigned to a quality assessment question and  
explanation of the score which are displayed in Table 2  
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Fig.3 Meta-analysis of the effect of protein and amino acids on body weight (kg)  
 
 
 
Fig. 4. Meta-analysis of the effect of protein supplementation (during ten days to six 
months) on lean body mass (kg) 
 
 
Bunout-A= no training, Bunout-B= training 
Fig. 5 Meta-analysis of the effect of vitamin D3 on leg strength 
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Fig. 6 Meta-analysis of the effect of protein on leg strength. 
 
 
Bunout 2006-A: no exercise intervention in both groups; Bunout 2006-B: with exercise inter-
vention in both groups. 
Fig. 7 Meta-analysis of the effect of vitamin D on hand grip strength (in kg). 
 
 
Bunout 2006-A: no exercise intervention in both groups; Bunout 2006-B: with exercise inter-
vention in both groups. 
Fig. 8 Meta-analysis of the effect of vitamin D on physical performance. 
 
 
 Fig. 9 Meta-analysis of the effect of vitamin D on walking capacity. 
 
 
Bunout 2006-A: no exercise intervention in both groups; Bunout 2006-B: exercise intervention 
in both groups. 
Fig. 10 Meta-analysis of the effect of vitamin D supplementation on TUG (s).
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Supplemental Material  
 
 
Supplemental Figure S1. Funnel plot of protein supplementation trials on body weight 
 
 
Supplemental figure S2. Subgroup analysis of the effect of protein supplementation on 
body weight. 
 
 
 
Supplemental figure S3. Subgroup analysis of the effect of 6 months of protein and L-
leucine supplementation on body weight.  
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Supplemental figure S4. Subgroup analysis of the effect ≥20 grams protein supplementa-
tion per day. 
 
 
Supplemental figure S5. Subgroup analysis of the effect protein and L-leucine supple-
mentation on body weight in “vulnerable older adults”. 
 
 
 
Supplemental figure S6. Subgroup analysis of trials that included exercise-training (in 
both protein groups as in placebo group) and that study the effect of protein supplemen-
tation on body weight.  
 
 
 
Supplemental figure S7. Sensitivity analysis (blinding of outcome assessors and treat-
ment providers) of the effect of protein/amino acid (AA) supplementation on body weight. 
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Supplemental figure S8. Funnel plot of the effect of vitamin D supplementation on physi-
cal performance. 
 
Bunout-A= no training, Bunout-B= training 
Supplemental figure S9. Subgroup-analysis of the effect 400-1000 IU vitamin D on TUG. 
